Corbus Pharmaceuticals maintains a 'Hold' rating as it advances CRB-701 for HNSCC and CRB-913 for obesity. Click here to read ...

T Coronae Borealis, a star system 3,000 light-years away, is expected to erupt as a nova in June 2026, briefly becoming ...

Corbus Pharmaceuticals announced results from its first-in-human dose escalation study of CRB-701, presented at the ASCO GU 2025 conference. This Phase 1 study assessed the efficacy and safety of ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

T Coronae Borealis (T CrB) is reappearing in the spring night sky, so be ready in case it goes nova. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Kansas City, Missouri, April 08, 2025 (GLOBE NEWSWIRE) -- CRB, a leading global provider of sustainable engineering, architecture, construction and consulting solutions to the life sciences and food & ...